With this notice, Frontiers states its awareness of misrepresentation of the availability of the 1st World Health Organization (WHO) International Standard (IS) for HDV RNA for nucleic acid amplification technique assays (code number 7657/12) in this article. The WHO IS is available from the Paul-Ehrlich-Institut, Langen, Germany (www.pei.de).

A correction has been made to Section 5 Challenges and perspectives, second paragraph. The original article has been updated.

Keywords

hepatitis D, HDV, HDV RNA, HDAg, anti-HDV, diagnosis, screening

Citation

Frontiers Editorial Office (2026) Correction: A comprehensive review of diagnostic approaches for hepatitis D. Front. Mol. Biosci. 13:1842937. doi: 10.3389/fmolb.2026.1842937

Received

30 March 2026

Accepted

30 March 2026

Published

17 April 2026

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

13 - 2026

Updates

Copyright

© 2026 Frontiers Editorial Office.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.